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ABSTRACT 
Objective: To discuss management strategies for patients 
presenting in the clinical setting with xerostomia (dry mouth). 
Xerostomia is a multifactorial problem and many times is 
disabling for the individual and challenging to manage. A 66 
year old Caucasian female presented to the dental hygiene 
clinic with a chief complaint of “constant dry mouth”.  The 
patient’s medical history indicated a previous habit of 
smoking along with a current history of asthma, chronic 
obstructive pulmonary disease, and oral candidiasis infection. 
Contributing factors to the patient’s dry mouth include: the 
use of a CPAP machine at night, oxygen during the day, and 
two prescription medications whose side effects cause dry 
mouth (Zoloft and Spiriva). Upon examination this patient 
was determined to be high caries risk with evidence of a new 
carious lesion on the mesial aspect of tooth #27. The iteration 
of meticulous home care is an important role of the clinician 
in order to alleviate discomfort, taste disturbances, sore 
mouth, and to prevent future decay and candidiasis 
infections. Other recommendations that were given in order 
to combat dry mouth included: use of high fluoride toothpaste 
(PreviDent 5000), ACT dry mouth rinse, and ACT dry mouth 
lozenges. It is also important for this patient to drink eight 
glasses of water a day, avoid sugar containing beverages, and 
chew sugar-free gum to stimulate salivation. The patients’ 
overall quality of life can be improved if clinicians are able to 
properly recognize xerostomia and recommend personalized 
management routines.  
    INTRODUCTION 
Xerostomia is defined as less than 1.5 ml unstimulated 
salivary flow in 15 minutes. Saliva is vital to the oral cavity 
to help clear debris and plaque from the teeth and aid as a 
buffer against acidity in the mouth. Due to a lack of salivary 
flow, xerostomic patients may have rampant dental caries. 
Other oral effects include dysgeusia (altered taste 
perception), dysarthria (speech difficulties), burning 
mouth, dysphagia (difficulty swallowing), odynophagia 
(painful swallowing), foul taste, halitosis (bad breath), and 
fungal infections. Patients with xerostomia will many times 
present with enlarged salivary glands and intra-oral 
candidiasis and/or angular chelitis.  The oral mucosa 
appears shiny and dehydrated and the dental mirror may 
stick to the tissues. Patients with Xerostomia must 
maintain regular dental therapy appointments in order to 
maintain optimal dental health. Radiographs must be 
prescribed periodically in order to detect decay. This 
condition is seen by dental hygienists on a daily basis. It is 
our obligation to provide quality care to these patients, 
prevent future caries, and alleviate discomfort. Patients are 
living longer and it is likely that the future of dentistry will 
deal more with patients who have dry mouth and 
management of this condition will become more complex. 
ASSESSMENT 
A 66 year old Caucasian female patient presented to the dental hygiene clinic for her 6 months recall 
appointment for dental hygiene therapy.  This patient had previously had scaling and root planing in 
2011 and presented for periodontal maintenance and exam. She reported having “constant dry mouth.” 
Clinical decay was found on the mesial #27. Her medical history showed that she had a history of 
hypertension, asthma. atrial fibrillation, cancer, chemotherapy, COPD, congestive heart failure,  
rheumatoid arthritis, and depression. This patient uses a CPAP machine at night and oxygen during the 
day. In order to make the patient comfortable, the clinician modified treatment by only leaning the 
patient halfway back in the chair to support her respiratory condition. 
 
EVALUATING XEROSTOMIC PATIENTS 
Treatment planning for the xerostomic patient should be tailored to 
the individual’s needs. Patient education is of the utmost importance 
for these patients. Information should be given regarding the potential 
sequelae of xerostomia including; caries, mucosal complication, and 
oral candidiasis. Emphasis should be put on daily oral hygiene regimen 
including brushing twice-daily, regular use of floss or other interdental 
cleaner, and use of an alcohol-free mouthrinse. Consultation with the 
patients physician may be considered if the dry mouth symptoms are 
likely caused from a systemic disease or due to medical treatment (i.e.: 
radiation therapy or prescription drugs-see table 3). Preventive 
measures are necessary for optimal care of patients with dry mouth. 
Preventive measures include: use of a high fluoride toothpaste, use of a 
“dry mouth” rinse, and “dry mouth” lozenges or sugar-free candies. It 
is also important for these patients to avoid sugar containing 
beverages, chew sugar-free gum to stimulate salivation, and maintain 
adequate hydration by drinking eight glasses of water per day. 
Temporary relief  from xerostomia can be accomplished by sipping  
water, sucking on ice, and using a humidifier during sleep. Tobacco use 
is associated with dry mouth and  the use of these products should be 
minimized or eliminated all together. The clinician should  be able to 
assess tobacco use, document oral mucosal changes, and integrate 
tobacco cessation counseling. Frequent dental visits every three to six 
months is recommended for these patients due to their high risk of 
developing caries and secondary infections (i.e.: candidiasis). If the 
patient’s unstimulated salivary flow is less than 1.5 ml in 15 minutes, 
pharmacotherapy with salivary stimulants such as Pilocarpine or 
Cevimeline may be prescribed. Pilocarpine should be used four times 
per day at 5 milligrams and Cevimeline is 30 mg three times per day. If 
the patient adheres to all of the clinicians recommendations the  
individuals will experience a more satisfying oral environment. 
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DENTAL HYGIENE TREATMENT PLAN 
The determined treatment plan was Periodontal maintenance (D4910) based on the patients history of scaling 
and root planning and current periodontitis evidenced by 4-5mm CAL.  This patient’s plaque score was 32%. 
The patient reported that her frequency of flossing was “seldom” and she usually brushed 2x/day. Oral hygiene 
instruction consisted of educating patient on Bass brushing method, brushing of the tongue, c-shaped flossing, 
and the use of a reach flosser. Patient responded to the recommendations well.  Upon DDS examination a new 
carious lesion was found on the mesial of #27 and  restorative work on #7 was indicated for cosmetic reasons. 
High caries risk was establish for this patient due to her present decay and xerostomic conditions. This patient 
also stated that she frequently sipped on sweetened beverages in between meals and occasionally snacked on 
fermentable carbohydrates. In office fluoride varnish 5% was applied and Prevident 5000 toothpaste was 
prescribed to be used once per day. Other individual recommendations given to this patient were to begin using 
ACT dry mouth lozenges,  and ACT dry mouth rinses. 
CONCULSION AND MANAGEMENT  
TEETH  
 Increased decay 
 Demineralization 
 Erosion and 
attrition 
 Increased 
sensitivity 
 Increase plaque 
accumulation 
 
LIPS 
 Dryness 
 Chapping 
 Peeling 
 Fissuring 
 Angular chelitits 
MUCOSA 
 Mucositis 
 Atrophic mucosa 
 Stomatitis and lichenoid 
lesions 
 Recurrent oral 
candidiasis 
 Ulcerations 
 Painful/Burning mouth 
 
SALIVARY GLANDS  
 Poor salivary output 
 Frothy saliva 
 Reduced salivary pooling 
 Swelling of glands 
 Enlargement of glands 
 Recurrent Sialadenitis 
 
TOUNGE 
 Dryness, Fissuring 
 Lobulation 
 Atrophy 
 Erythema 
 Loss of papilla 
 Scalloped borders 
 
 
 
OTHER 
 Halitosis 
 Difficulty talking, 
chewing, or swallowing 
 Altered taste 
 Food retention  
 Nutritional deficiencies 
 Dry eyes associated  
      with dry mouth  
1. Montgomery-Cranny J, Hodgson T, Hegarty A. Aetiology and management 
of xerostomia and salivary gland hypofunction. British Journal of Hospital 
Medicine. 2014;75(9):509-514.  
1. Montgomery-Cranny J, Hodgson T, Hegarty A. Aetiology and management 
of xerostomia and salivary gland hypofunction. British Journal of Hospital 
Medicine. 2014;75(9):509-514.  
2. Plemons J, Al-Hashimi I, Marek C. Managing xerostomia and salivary gland hypofunction. 
The Journal of the American Dental Association. 2014; 145 (8):867-873.  
